SCHEMBL31508124

SCHEMBL31508124

Cc1nc([N+](=O)[O-])ccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
MAPT P10636 2/20 0.41
SOS1 Q07889 1/20 0.40
KDM4E B2RXH2 1/20 0.39
GAA P10253 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2C19 P33261 1/20 0.38
HIF1A Q16665 1/20 0.37
F2 P00734 1/20 0.37
PLAU P00749 1/20 0.37
KLKB1 P03952 1/20 0.37
ELANE P08246 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
VCAM1 P19320 1/20 0.35
S1PR4 O95977 1/20 0.35
LMNA P02545 1/20 0.35
ACHE P22303 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ATM Q13315 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28029436 0.79 ALDH1A1 (0.44) ALDH1A1MAPTKDM4EGAAACHE
Ammonia Solution, Strong SCHEMBL27768089 0.78 ALDH1A1 (0.43) ALDH1A1MAPTKDM4EGAAACHE
SCHEMBL117763 0.76 CTSB (0.44) ALDH1A1MAPTKDM4EGAAHIF1A
SCHEMBL30227675 0.76 CTSB (0.44) ALDH1A1MAPTKDM4EGAAHIF1A
SCHEMBL20969963 0.76 ALDH1A1 (0.37) ALDH1A1MAPTSOS1KDM4EGAA
SCHEMBL26126786 0.76 ALDH1A1 (0.46) ALDH1A1MAPTKDM4EGAAACHE
SCHEMBL2488382 0.76 ALDH1A1 (0.41) ALDH1A1MAPTKDM4EGAALMNA
SCHEMBL2728835 0.76 ALDH1A1 (0.41) ALDH1A1MAPTSOS1KDM4EGAA
Hydrochloric Acid SCHEMBL20969960 0.74 ALDH1A1 (0.36) ALDH1A1MAPTSOS1KDM4EGAA
Hydrochloric Acid SCHEMBL20969959 0.74 ALDH1A1 (0.36) ALDH1A1MAPTSOS1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12384773-B2 Thiazole compounds and methods of use thereof ARCUS BIOSCIENCES, INC. (US) 2025-08-12 US disclosed
WO-2025096979-A1 THIAZOLE COMPOUNDS AS KIT INHIBITORS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2025-05-08 WO disclosed
US-20250145606-A1 THIAZOLE COMPOUNDS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2025-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12384773-B2 Thiazole compounds and methods of use thereof TPMT, CYP11B2, ABAT ALDH1A1 198/4885MAPT 1247/4885SOS1 2848/4885
US-20250145606-A1 THIAZOLE COMPOUNDS AND METHODS OF USE THEREOF TPMT, CYP11B2, ABAT ALDH1A1 198/4885MAPT 1247/4885SOS1 2848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.